Business
PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference
BOSTON, January 06, 2026--PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference
About this update from Puretech Health Plc
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":7367,"height":2362,"url":"https://media.zenfs.com/en/business-wire.com/f1828a4caf3cb498322c56c1e24c3851"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Uh46jl9HqJr.0glutuJ_9A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMwODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/f1828a4caf3cb498322c56c1e24c3851","width":960,"height":308},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/_3neydtQ7qDztrQB_8JIiw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD03NzA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/f1828a4caf3cb498322c56c1e24c3851","width":1200,"height":385}},"lazy":false},{"type":"text","content":"BOSTON, January 06, 2026--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, today announced that Robert Lyne, Chief Executive Officer, will present at the 44th annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 4:30pm PST / 7:30pm EST. A webcast of the presentation will be available at https://investors.puretechhealth.com.","length":529,"tagName":"p"},{"type":"text","content":"About PureTech Health","length":21,"tagName":"p"},{"type":"text","content":"PureTech Health is a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value. We do this through a proven, capital-efficient R&D model focused on opportunities with validated pharmacology and untapped potential to address significant patient needs. This strategy has produced dozens of therapeutic candidates, including three that have received U.S. FDA approval. By identifying, shaping, and de-risking these high-conviction assets, and scaling them through dedicated structures backed by external capital, we accelerate their path to patients while creating sustainable value for shareholders.","length":656,"tagName":"p"},{"type":"text","content":"For more information, visit www.puretechhealth.com or connect with us on X (formerly Twitter) @puretechh.","length":105,"tagName":"p"},{"type":"text","content":"Cautionary Note Regarding Forward-Looking Statements","length":52,"tagName":"p"},{"type":"t...